Immunovant Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Immunovant stock ranges from a low of $16 to a high of $45. The average analyst price target of $27.71 forecasts a 21.32% increase in the stock price over the next year.

Price Target: $27.71 (+21.32%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$27.71	$30	$45
Change	-29.95%	+21.32%	+31.35%	+97.02%

* Price targets were last updated on Oct 14, 2025.

Analyst Ratings

The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	3	3	3	3	3
Buy	5	5	5	4	2	2
Hold	2	3	3	3	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	11	10	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Danielle Brill Truist Securities	Truist Securities	Hold Initiates $16	Hold	Initiates	$16	-29.95%	Oct 14, 2025
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $37 → $33	Buy	Maintains	$37 → $33	+44.48%	Sep 30, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+53.24%	Sep 4, 2025
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $40 → $37	Buy	Maintains	$40 → $37	+62.00%	Aug 12, 2025
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $33 → $30	Strong Buy	Maintains	$33 → $30	+31.35%	Aug 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

28.80M

EPS This Year

-2.99

from -2.73

EPS Next Year

-2.96

from -2.99

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	-	-	-	-	-	28.80M
Revenue Growth	-	-	-	-	-	-	-
EPS	-1.22	-1.43	-1.71	-1.88	-2.73	-2.99	-2.96
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	90.7M
Avg	n/a	28.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.67	-2.06
Avg	-2.99	-2.96
Low	-3.18	-3.87

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.